Royal Bank of Canada’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-249,138
Closed -$134K 6829
2024
Q4
$134K Buy
249,138
+187,381
+303% +$101K ﹤0.01% 4690
2024
Q3
$109K Buy
61,757
+60,696
+5,721% +$107K ﹤0.01% 4842
2024
Q2
$1K Sell
1,061
-1,227
-54% -$1.16K ﹤0.01% 6564
2024
Q1
$21K Sell
2,288
-13,076
-85% -$120K ﹤0.01% 5464
2023
Q4
$167K Buy
15,364
+8,507
+124% +$92.5K ﹤0.01% 4734
2023
Q3
$55K Sell
6,857
-582
-8% -$4.67K ﹤0.01% 5251
2023
Q2
$81K Buy
7,439
+6,983
+1,531% +$76K ﹤0.01% 5052
2023
Q1
$3K Buy
456
+400
+714% +$2.63K ﹤0.01% 6334
2022
Q4
$0 Buy
56
+4
+8% ﹤0.01% 7313
2022
Q3
$0 Buy
52
+5
+11% ﹤0.01% 7430
2022
Q2
$0 Sell
47
-2,269
-98% ﹤0.01% 7263
2022
Q1
$21K Sell
2,316
-5,584
-71% -$50.6K ﹤0.01% 6106
2021
Q4
$94K Buy
7,900
+4,593
+139% +$54.7K ﹤0.01% 5471
2021
Q3
$38K Buy
3,307
+716
+28% +$8.23K ﹤0.01% 5810
2021
Q2
$46K Buy
2,591
+153
+6% +$2.72K ﹤0.01% 5607
2021
Q1
$38K Buy
2,438
+2,131
+694% +$33.2K ﹤0.01% 5563
2020
Q4
$4K Buy
307
+229
+294% +$2.98K ﹤0.01% 6203
2020
Q3
$1K Sell
78
-196
-72% -$2.51K ﹤0.01% 6010
2020
Q2
$2K Sell
274
-4,053
-94% -$29.6K ﹤0.01% 5849
2020
Q1
$35K Buy
4,327
+4,312
+28,747% +$34.9K ﹤0.01% 4822
2019
Q4
$0 Buy
+15
New ﹤0.01% 6406
2019
Q3
Sell
-1,575
Closed -$26K 6241
2019
Q2
$26K Sell
1,575
-4
-0.3% -$66 ﹤0.01% 4859
2019
Q1
$26K Sell
1,579
-50
-3% -$823 ﹤0.01% 4796
2018
Q4
$19K Sell
1,629
-133
-8% -$1.55K ﹤0.01% 4881
2018
Q3
$70K Buy
+1,762
New +$70K ﹤0.01% 4467
2017
Q3
Sell
-1
Closed 6174
2017
Q2
$0 Buy
+1
New ﹤0.01% 5991